Frontiers of COVID-19

Section I. History, Epidemiologic Background and Pathogenesis of Coronavirus.- Chapter 01: Surfaces as a source for SARS-CoV-2 transmission.- Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance.- Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system.- Chapter 04: Genetics and Biological characteristics of SARS-CoV-2.- Chapter 05: COVID-19 impact on host at pathophysiological and cellular level.- Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design.- Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies.- Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2.- Chapter 09: Emergence of COVID-19 variants and its global impact.- Section II. Clinical Observations.- Chapter 10: Psychological Impacts of the COVID-19 Pandemic.- Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications.- Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19.- Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic.- Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines.- Chapter 15: Post COVID-19 conditions-the new challenge to mankind.- Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials.- Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours.- Chapter 18: Neurological Complications of COVID-19.- Chapter 19: The Impact of Covid-19 on Surgical Disease.- Section III. Interventions and Treatments.- Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective.- Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19.- Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19.- Section IV. Current Trends and Future Directions.- Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy.- Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges.- Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms.- Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination.- Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !?.- Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021.- Chapter 29: The Global Evolution of Clinical Practice During a Pandemic.- Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19.- Chapter 31. The road ahead

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Epidemiologia e estatística médica
• Doenças infecciosas e contagiosas

novel coronavirus disease;pandemic;antibody;infection;herd immunity;vaccine